Salim Yazji

Chief Medical Officer, Oncternal Therapeutics, Inc.

Companies

Oncternal Therapeutics, Inc.Chief Medical Officer May 27, 2021 to Feb 15, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 3, 2024Shares withheld for tax 19,742 shares at $0.50 of Oncternal Therapeutics, Inc.²
Jul 3, 2023Shares withheld for tax 16,299 shares at $0.36 of Oncternal Therapeutics, Inc.³
Apr 14, 2023Bought 5,000 shares at $0.30 of Oncternal Therapeutics, Inc.⁴
Apr 13, 2023Bought 10,000 shares at $0.29 of Oncternal Therapeutics, Inc.⁴
Apr 12, 2023Bought 10,000 shares at $0.29 of Oncternal Therapeutics, Inc.⁴
Jan 3, 2023Shares withheld for tax 9,961 shares at $1.02 of Oncternal Therapeutics, Inc.⁵
Jul 28, 2022Granted 82,500 shares of Oncternal Therapeutics, Inc.⁶
Jan 27, 2022Bought 10,000 shares at $1.69 of Oncternal Therapeutics, Inc.⁷
Jan 3, 2022Granted 57,137 shares of Oncternal Therapeutics, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.